{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:15:44Z","timestamp":1788509744292,"version":"build-2803163510"},"reference-count":27,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The first therapeutic assessment of locally advanced (LA) head and neck squamous cell carcinomas (HNSCCs) is often performed 10\u201312 weeks after the end of chemoradiotherapy as a result of the delayed action of radiotherapy. Diagnostic uncertainty between persistent disease and treatment-related changes (oedema, necrosis) can delay confirmation of residual cancer. According to data in the literature, a correlation exists between the detection of circulating tumour DNA (ctDNA) at the end of chemoradiotherapy treatment and residual disease. However, additional data are required before this molecular tool can be used in routine clinical practice. The aim of this clinical trial (NeckTAR-IN) is to assess the usefulness of ctDNA to detect residual disease 3 months after the end of chemoradiotherapy among patients with LA HNSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>At M3, objective response (clinical and radiological) will be set against the detection or not of ctDNA in the blood. This is an interventional, multicentre, prospective trial, ancillary to the NeckTAR study. All the patients included in the NeckTAR study are eligible for the NeckTAR-IN study. We expect to enrol 59 patients in this ancillary trial. A blood sample will be taken 1\u2009month and 3\u2009months after the end of chemoradiotherapy. Approval from the ethics committee was granted on 29 August 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol obtained approval from the French Ethics Committee (N\u00b025.02461.000435). The results will be published in scientific journals and presented at conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial results\" xlink:href=\"NCT07178847\">NCT07178847<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-118532","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:40:28Z","timestamp":1786110028000},"page":"e118532","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07178847","registry":"10.18810\/clinical-trials-gov","type":"results"},{"clinical-trial-number":"nct05710679","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05710679","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-0876","authenticated-orcid":false,"given":"Angeline","family":"Ginzac","sequence":"first","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Clinical Investigation Center, UMR501, Clermont-Ferrand, France"},{"name":"Clinical Research Division, Delegation for Clinical Research and Innovation, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Ventelou","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-C\u00e9leste","family":"Ferreira","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"OncoGenAuvergne Laboratory, Pathology Unit, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Canetti","sequence":"additional","affiliation":[{"name":"OncoGenAuvergne Laboratory, Pathology Unit, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Biau","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Radiotherapy Department, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Molnar","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Clinical Investigation Center, UMR501, Clermont-Ferrand, France"},{"name":"Clinical Research Division, Delegation for Clinical Research and Innovation, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Ponelle-Chachuat","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Oncogenetics Department, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soline","family":"Philippe","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Clinical Investigation Center, UMR501, Clermont-Ferrand, France"},{"name":"Clinical Research Division, Delegation for Clinical Research and Innovation, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Saroul","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology - Head and Neck Surgery, Gabriel Montpied University Hospital Center, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pham-Dang","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery, Estaing University Hospital Center, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Durando","sequence":"additional","affiliation":[{"name":"INSERM, U1240, Molecular Imaging and Theranostic Strategies, Jean Perrin Center, University of Clermont Auvergne, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Clinical Investigation Center, UMR501, Clermont-Ferrand, France"},{"name":"Clinical Research Division, Delegation for Clinical Research and Innovation, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Medical Oncology Department, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Bernadach","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Delegation for Clinical Research and Innovation, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"},{"name":"Medical Oncology Department, Jean Perrin Centre, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026090400401090000_16.8.e118532.1","doi-asserted-by":"crossref","DOI":"10.3390\/medsci11020042","article-title":"Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma","volume":"11","author":"Barsouk","year":"2023","journal-title":"Med Sci (Basel)"},{"key":"2026090400401090000_16.8.e118532.2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/0-306-48060-3_2","article-title":"Epidemiology, staging, and screening of head and neck cancer","volume":"114","author":"Argiris","year":"2003","journal-title":"Cancer Treat Res"},{"key":"2026090400401090000_16.8.e118532.3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"The Lancet"},{"key":"2026090400401090000_16.8.e118532.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602510"},{"key":"2026090400401090000_16.8.e118532.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"2026090400401090000_16.8.e118532.6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CCO.0b013e3283388906","article-title":"Advances in radiotherapy of head and neck cancers","volume":"22","author":"Tao","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"2026090400401090000_16.8.e118532.7","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23341"},{"key":"2026090400401090000_16.8.e118532.8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3603"},{"key":"2026090400401090000_16.8.e118532.9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000452861","article-title":"Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?","volume":"84","author":"van Ginkel","year":"2017","journal-title":"Pathobiology"},{"key":"2026090400401090000_16.8.e118532.10","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/cam4.4726","article-title":"Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma","volume":"11","author":"Kogo","year":"2022","journal-title":"Cancer Med"},{"key":"2026090400401090000_16.8.e118532.11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/cncr.34109","article-title":"Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer","volume":"128","author":"O\u2019Boyle","year":"2022","journal-title":"Cancer"},{"key":"2026090400401090000_16.8.e118532.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.02.012"},{"key":"2026090400401090000_16.8.e118532.13","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10254"},{"key":"2026090400401090000_16.8.e118532.14","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.3390\/curroncol30100643","article-title":"Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay","volume":"30","author":"Koukourakis","year":"2023","journal-title":"Curr Oncol"},{"key":"2026090400401090000_16.8.e118532.15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/IJPM.IJPM_28_20","article-title":"Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma","volume":"63","author":"Verma","year":"2020","journal-title":"Indian J Pathol Microbiol"},{"key":"2026090400401090000_16.8.e118532.16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/ijc.33287","article-title":"Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck","volume":"148","author":"Tanaka","year":"2021","journal-title":"Int J Cancer"},{"key":"2026090400401090000_16.8.e118532.17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.07.027","article-title":"Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy","volume":"151","author":"Hilke","year":"2020","journal-title":"Radiother Oncol"},{"key":"2026090400401090000_16.8.e118532.18","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.e18003","article-title":"Clinical utility of circulating tumor DNA in patients with head and neck cancers","volume":"40","author":"Onyshchenko","year":"2022","journal-title":"JCO"},{"key":"2026090400401090000_16.8.e118532.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2026090400401090000_16.8.e118532.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11136-2","article-title":"Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial","volume":"23","author":"Ginzac","year":"2023","journal-title":"BMC Cancer"},{"key":"2026090400401090000_16.8.e118532.21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn011"},{"key":"2026090400401090000_16.8.e118532.22","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091418","article-title":"Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients","volume":"13","author":"Kampel","year":"2023","journal-title":"Biomolecules"},{"key":"2026090400401090000_16.8.e118532.23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133118","article-title":"Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC","volume":"13","author":"Burcher","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026090400401090000_16.8.e118532.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0110"},{"key":"2026090400401090000_16.8.e118532.25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113303","article-title":"Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer","volume":"19","author":"Lin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026090400401090000_16.8.e118532.26","doi-asserted-by":"crossref","first-page":"106358","DOI":"10.1016\/j.oraloncology.2023.106358","article-title":"Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)","volume":"139","author":"Economopoulou","year":"2023","journal-title":"Oral Oncol"},{"key":"2026090400401090000_16.8.e118532.27","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1002\/onco.13573","article-title":"The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma","volume":"26","author":"Wilson","year":"2021","journal-title":"Oncologist"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-118532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:40:18Z","timestamp":1788507618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-118532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-118532"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-118532","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}